ArticleBMC infectious diseases2026
Measles-rubella surveillance and its facilitators and barriers in Bagmati province, Nepal: a mixed methods study.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Measles outbreaks in Nepal: sustaining rapid response through equity-focused immunization and surveillance.Annals of medicine and surgery (2012) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNepal committed to eliminate measles-rubella by 2023 by implementing the ‘Strategic plan for measles and rubella elimination in WHO South-East Region:2020–2024’. Following the impact of the pandemic on the national immunization program and services, Nepal has now revised its target to achieve elimination by 2026. High vaccine coverage and effective surveillance systems are indispensable to achieve measles elimination. This study aimed to assess the status of measles-rubella surveillance and understand the facilitators and barriers for the measles-rubella surveillance activities in selected municipalities of selected districts of Bagmati province of Nepal.
methodsA convergent parallel mixed method study was conducted, incorporating both quantitative and qualitative approaches. It was done in eight municipalities of the three districts which were purposively selected. Eight municipalities, including both rural and urban areas, were selected from the three districts. The health facilities included in the study were: a) All the health facilities that are part of the WHO reporting unit (RU) for Vaccine-Preventable Disease (VPD) surveillance b) purposively selected health facilities outside the WHO RU. A total of 14 Key Informant Interviews (KIIs) were conducted with district and municipal stakeholders. For in-depth interviews (IDIs), two World Health Organization-Surveillance Medical Officers (WHO-SMOs) overseeing VPD surveillance and immunization activities in these districts, along with a VPD surveillance focal person from each selected reporting and non-reporting health facility, were purposively selected.
resultsThe key strategies to achieve measles elimination, that is the MR2 coverage of 95%, was not achieved in most of the municipalities. The main barriers to effective VPD surveillance among others included limited awareness of VPDs under surveillance, poor understanding of the measles elimination target, and lack of clarity on standard case definitions (SCDs) for suspected measles-rubella cases. The major facilitators for effective VPD surveillance included awareness on the importance of VPD surveillance in measles elimination, availability of standard case definition posted in all reporting health facilities, and timely case notification and investigation by RUs.
conclusionsThis study suggests that measles-rubella surveillance in the study sites can be strengthened through capacity building of health workers in VPD surveillance, ensuring the availability of the VPD surveillance field guide, availability of the dedicated focal person, emphasizing in data analysis and utilization of surveillance data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.